|
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2014
|
Dec. 31, 2013
|
| Cash flows from operating activities: |
|
|
| Net loss |
$ (9,246) |
$ (4,899) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization of deferred charges |
106 |
97 |
| Stock based compensation related to shares and warrants granted to service providers |
198 |
227 |
| Stock-based compensation related to options granted to employees |
1,024 |
674 |
| Increase in accounts receivable and prepaid expenses |
(93) |
(155) |
| Increase (decrease) in trade payables |
1,314 |
(130) |
| Increase in other accounts payable and accrued expenses |
467 |
306 |
| Revaluation of warrants |
1,743 |
(174) |
| Total net cash used in operating activities |
(4,487) |
(4,054) |
| Cash flows from investing activities: |
|
|
| Purchase of property and equipment |
(161) |
(108) |
| Changes in short-term deposit |
(4,290) |
2,769 |
| Investment in lease deposit |
1 |
(5) |
| Total net cash provided by (used in) investing activities |
(4,450) |
2,656 |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of Common stock, net |
9,554 |
3,576 |
| Proceeds from exercise of warrants and options |
731 |
8 |
| Redemption of warrants in cash |
(600) |
0 |
| Total net cash provided by financing activities |
9,685 |
3,584 |
| Increase (decrease) in cash and cash equivalents |
748 |
2,186 |
| Cash and cash equivalents at the beginning of the period |
3,503 |
1,317 |
| Cash and cash equivalents at end of the period |
4,251 |
3,503 |
| Non-cash financing activities: |
|
|
| Stock issued for warrants exchange |
1,633 |
0 |
| Warrants liability classified as equity |
$ 42 |
$ 0 |